Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2022-03-22 00:00:00 ET · period of report 2022-03-21 · accession 0001062993-22-008344 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-22 | 2022-03-21 | ENTA | CARTER BRUCE L A | Dir | S - Sale+OE | $67.83 | -6,000 | 0 | -100% | -$407.0K |
| D | 2022-03-22 | 2022-03-21 | ENTA | CARTER BRUCE L A | Dir | M - OptEx | $25.58 | +6,000 | 6,000 | New | +$153.5K |
| D | 2022-03-22 | 2022-03-21 | ENTA | CARTER BRUCE L A | Dir | M - OptEx | $0.00 | -6,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | S | D | 307 | $67.23 | 3,017 | D | — | — | (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $67.005 to $67.47, inclusive. |
| 2 | Common | Common Stock | 2022-03-21 | S | D | 2,676 | $66.70 | 3,324 | D | — | — | (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $66.28 to $66.99, inclusive. |
| 3 | Common | Common Stock | 2022-03-21 | M | A | 6,000 | $25.58 | 6,000 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-21 | S | D | 2,210 | $68.66 | 807 | D | — | — | (F4) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $68.509 to $68.76, inclusive. |
| 5 | Common | Common Stock | 2022-03-21 | S | D | 807 | $69.52 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $69.39 to $70.07, inclusive. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-03-21 | M | D | 6,000 | $0.00 | 0 | D | $25.58 · — to 2026-02-11 | 6,000 Common Stock | (F6) 100% of the shares subject to the option are fully vested and exercisable. |